Full-Time

Area Business Manager Oncology Breast Cancer

Mountain West

Updated on 9/9/2026

Deadline 9/10/26
Pfizer

Pfizer

10,001+ employees

Biopharmaceutical company develops medicines and vaccines

Compensation Overview

$139k - $280.4k/yr

+ Sales incentive bonus

No H1B Sponsorship

Remote in USA + 3 more

More locations: Washington, USA | California, USA | Colorado, USA

Hybrid

Extensive travel and field work are required; relocation assistance may be available based on eligibility.

Bachelor's, Master's, MBA

Category
Sales & Account Management (1)
Required Skills
CRM
Data Analysis

Get referred to Pfizer

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • At least 6 years of pharmaceutical, biotechnology, or medical marketing or sales experience is required.
  • Candidates must live within a commutable distance to the territory.
  • Candidates must be willing to travel as needed to develop internal and external relationships.
  • Candidates must have strong communication skills, including the ability to think and communicate with the audience's needs first.
  • Candidates must have a valid United States driver's license and a driving record compliant with company standards; any DUI, DWI, or other impaired-driving citation within the past 7 years disqualifies the candidate.
  • Candidates must demonstrate a cross-functional collaboration mindset to facilitate the One Pfizer commitment to customers.
  • Candidates must model excellence in change, agility, and adaptability.
  • Candidates must demonstrate diverse leadership experiences and capabilities, including influencing and collaborating with peers, developing and coaching others, and overseeing and guiding colleagues' work to achieve meaningful outcomes and business impact.
  • Candidates must be skilled in data-driven resource management to ensure proper channel deployment.
Responsibilities
  • Supervise and lead 5–8 Senior Oncology Account Specialists within the assigned area.
  • Own sales performance for the business portfolio of products and maintain business knowledge of the area landscape to assess key stakeholders and future marketplace trends.
  • Provide regular in-field and virtual coaching and observation of Field Sales Representatives and maintain frequent customer contact.
  • Develop effective partnerships with marketing and channel colleagues.
  • Ensure compliant execution by team members by driving understanding of relevant policies and guidance and advancing a culture of integrity.
  • Supervise area operations, including hiring, live coaching, virtual coaching, representative development, performance management, and assignment of priority accounts within the medical community.
  • Develop and implement strategic plans and the area business plan, and own area-level budgets in alignment with Regional Business Director expectations.
  • Plan, organize, and monitor performance to achieve the business potential of the area and regional business unit.
  • Ensure effective utilization of promotional material, contribute to annual marketing plans, measure field implementation, and assess marketing activities as part of marketing operations.
  • Conduct proactive data analysis to identify market trends.
  • Identify, motivate, and develop key account opportunities that affect regional and national business.
  • Build relationships with customers, including key opinion leaders, and stakeholders including area and regional management teams, channel partners, and cross-functional partners.
  • Develop external advocates and contribute to advocacy and community engagement as needed.
  • Champion cross-functional collaboration to deliver on customer needs while ensuring representatives respect compliance guardrails.
  • Coach representatives on connecting cross-functional colleagues to address customer needs and using artificial intelligence and other digital tools.
  • Plan and conduct plans of action and other meetings with area management teams, channel partners, and cross-functional partners.
  • Collaborate effectively within integrated account teams.
  • Partner with Marketing to develop key strategies, business imperatives, and objectives during the operating plan process.
  • Ensure cross-functional partnerships across Pfizer markets and customers to build effective relationships and conduct face-to-face selling.
  • Lead cross-functional partnerships to ensure patient services are delivered as needed.
  • Maintain enhanced product and portfolio, disease-state, and market knowledge to answer customer and representative questions accurately.
  • Operate digital and virtual tools and platforms effectively.
  • Leverage insights from new analytics tools, such as 360-degree customer insights.
  • Use systematic approaches to virtual engagement, including clear agendas and next steps or follow-ups.
  • Manage time flexibly between face-to-face and virtual engagements to maximize healthcare professional engagement across large geographies.
  • Coach and counsel area team members on performance and selling-skill execution, product knowledge, capabilities, and business-plan development.
  • Ensure personal and team actions comply with relevant policies and processes, escalate issues as necessary, and reinforce integrity within the team.
  • Implement and uphold area standards with sales colleagues.
  • Apply situational leadership by aligning intervention and coaching with colleagues' developmental levels during customer engagements.
  • Use interactive coaching methods across engagement types, including virtual ride-alongs, chat-based shadowing, and face-to-face and virtual coaching.
  • Build strong team culture, colleague engagement, and morale.
  • Promote a feedback culture and continuous improvement by assessing customer experience through pulse surveys, team barometers, and customer feedback.
  • Set team goals and hold team members accountable for exceeding goals related to brand growth, time management, technical knowledge, communication, compliance, technology use, and live and virtual engagements.
Desired Qualifications
  • Experience working with key thought leaders or high-influence customers in large group practices, hospitals, or managed care organizations.
  • Experience as an Oncology Sales Enablement Manager or Area Business Manager and breast cancer therapeutic experience.
  • At least 2 years of commercial oncology experience.
  • An MBA or relevant graduate degree.
  • Advanced communication skills for facilitation, customer engagement, team management, and remote collaboration and coaching.
  • Ability to think strategically and execute effectively to deliver results.
  • A strong track record of collaborative and motivational leadership and internal stakeholder management.
  • Experience collaborating with external partners.

Pfizer is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a range of health needs, including vaccines, oncology, and other specialized therapies. Its products work by using biological mechanisms to prevent or treat diseases—vaccines train the immune system to fight infections, while medicines target cancer and other conditions. Pfizer differentiates itself through its large worldwide footprint, broad portfolio across multiple therapeutic areas, and partnerships (notably with BioNTech) that expanded its reach in vaccines and cutting-edge therapies. The company also engages in public health initiatives, such as efforts to provide vaccines to underserved populations. Pfizer’s broad goal is to improve global health by delivering safe and effective medicines and vaccines through research, development, and wide international distribution.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • On August 4, 2026, Pfizer raised revenue guidance to $60.5-$62.5 billion.
  • Eliquis grew 19% and Padcev 23% in Q2 2026.
  • Pfizer expects $2.5 billion additional savings from 2027-2029.

What critics are saying

  • Eliquis faces generic erosion after 2026, pressuring Pfizer’s largest non-COVID cash engine.
  • Reuters reported July 9, 2026, AstraZeneca defeated Pfizer’s Wyeth Tagrisso patent claims.
  • Without a post-Eliquis blockbuster, Pfizer becomes a shrinking dividend utility by 2028.

What makes Pfizer unique

  • Pfizer pairs global commercial scale with Seagen-era oncology assets and vaccine manufacturing.
  • Eliquis, Padcev, and Vyndaqel prove Pfizer can replace COVID revenue with launches.
  • Pfizer’s 2026 FDA-cleared XFG Comirnaty keeps its mRNA platform commercially relevant.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

-5%

1 year growth

-5%

2 year growth

-5%
Yahoo Finance
Aug 28th, 2026
Pfizer's updated COVID vaccine ships as FDA approves narrower rollout for over-65s and high-risk groups

Pfizer received FDA approval for its updated Comirnaty COVID-19 vaccine on Thursday, with deliveries to pharmacies and clinics beginning immediately. The company's shares were trading at $27.9079 on 28 August. However, the market opportunity has significantly narrowed from pandemic levels. Eligibility is now limited to adults aged 65 and older, plus higher-risk patients aged 5 through 64. Despite Comirnaty having distributed over five billion doses worldwide historically, today's revenue potential is considerably more constrained. Pfizer faces competition from Moderna and the Novavax-Sanofi protein vaccine for this smaller patient pool. The company's current share price sits 5.27% above its estimated value of $26.51, suggesting investors are paying a premium before actual uptake and commercial results become clear.

Associated Press
Aug 27th, 2026
FDA approves Pfizer-BioNTech XFG-adapted COVID-19 vaccine for high-risk groups

Pfizer and BioNTech have received US Food and Drug Administration (FDA) approval for their 2026-2027 COVID-19 vaccine targeting the XFG variant. The vaccine is approved for adults aged 65 and older, and individuals aged 5 to 64 with underlying conditions that increase risk of severe COVID-19 outcomes. The FDA approval is based on clinical, non-clinical and real-world data demonstrating the vaccine generates strong immune responses against currently circulating SARS-CoV-2 variants, including XFG and other contemporary lineages. The XFG variant was selected following FDA guidance for fall 2026 vaccine composition. The vaccine will begin shipping immediately and will be available in US pharmacies, hospitals and clinics within days. To date, more than five billion doses of COMIRNATY have been distributed globally.

Yahoo Finance
Aug 24th, 2026
Pfizer and J&J navigate patent cliffs with newer drugs offsetting blockbuster losses

Pfizer and Johnson & Johnson are navigating patent cliffs as key drugs lose exclusivity, with their latest results showing differing stages of transition. Pfizer's revenue excluding COVID products grew 5% operationally in Q2 2026, with newer medicines like Padcev and Vyndaqel contributing. The company expects $9.7 billion in cost savings through 2029 to support margins during the transition. Johnson & Johnson's Innovative Medicine sales rose 7.8%, despite Stelara revenue declining 55%. Tremfya sales surged 72.5% to $2 billion, helping offset losses alongside growth from oncology and neuroscience products. Johnson & Johnson raised 2026 guidance, with reported sales expected to reach $101.1 billion and adjusted EPS of $11.68. Its MedTech division provides additional diversification that pure pharmaceutical company Pfizer lacks, suggesting Johnson & Johnson's transition is more advanced.

Yahoo Finance
Aug 19th, 2026
Intel CEO invests $10M in shares as chipmaker posts 25% revenue growth driven by AI demand

Intel CEO Lip-Bu Tan purchased nearly $10 million worth of shares as part of the chipmaker's recent stock offering, signalling confidence in the company's turnaround. Intel recently reported revenues of $16.1 billion, growing 25% year-over-year, with its Data Centre and AI business unit seeing revenue surge nearly 60% to $6.3 billion. CoStar Group founder and CEO Andrew Florance purchased 83,300 shares totalling roughly $2.5 million. Pfizer CEO Albert Bourla similarly invested, purchasing 38,000 shares for just over $1 million. These insider purchases reflect executives' confidence in their companies' longer-term outlook, with investors often viewing such moves as a positive signal.

Yahoo Finance
Aug 18th, 2026
Two profitable stocks with solid fundamentals and one to ignore

Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.